跳至主要內容

臺北市資料大平臺

:::

Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment.
員工報告

檔案下載

資料項目檔案大小檔案格式更新時間操作

詮釋資料

計畫摘要 Ocular hypertension is a major risk factor for the development and progression of glaucoma. Frequent and long-term application of latanoprost often causes undesirable local side effects, which are a major cause of therapeutic failure due to loss of persistence in using this glaucoma medical therapy. In the present study, we developed a thermosensitive chitosan-based hydrogel as a topical eye drop formulation for the sustained release of latanoprost to control ocular hypertension. The developed formulation without preservatives may improve compliance and possibly even efficacy. The results of this study support its biocompatibility and sustained-release profile both in vitro and in vivo. After topical application of latanoprost-loaded hydrogel, triamcinolone acetonide-induced elevated intraocular pressure was significantly decreased within 7 days and remained at a normal level for the following 21 days in rabbit eyes. This newly developed chitosan-based hydrogel may provide a non-invasive alternative to traditional anti-glaucoma eye drops for glaucoma treatment.
資料集研究(主辦)機關 衛生局聯合醫院
年度 105
研究人員 Cheng YH(鄭詠馨), Tsai TH (蔡東湖)., Jhan YY, Chiu AW, Tsai KL, Chien CS, Chiou SH, Liu CJ.
關鍵詞 期刊
備註 本專區110年以前為歷史轉檔資料,因新舊平臺欄位規格不同,故有部分詮釋資料欄位無資訊;如對資料內容有疑義,請洽資料集主辦機關或本府研考會研究發展組。